Beauty Health (NASDAQ:SKIN) Rating Increased to Strong-Buy at Zacks Research

Key Points

• Beauty Health's stock rating has been upgraded from "hold" to a "strong-buy" by Zacks Research, indicating increased analyst confidence in the company's potential.
• Following recent analysts' assessments, Beauty Health's stock has a mixed outlook with one Strong Buy, one Buy, four Holds, and one Sell rating, along with a consensus target price of $2.81.
• The company's quarterly earnings report showed a profit of $0.03 per share, which surpassed analysts' expectations of a loss, contributing to a positive market response.

Beauty Health (NASDAQ:SKIN - Get Free Report) was upgraded by stock analysts at Zacks Research from a "hold" rating to a "strong-buy" rating in a research note issued to investors on Tuesday,Zacks.com reports.

A number of other research analysts have also recently weighed in on the stock. TD Cowen lifted their price objective on shares of Beauty Health from $2.00 to $2.50 and gave the company a "hold" rating in a report on Monday, September 22nd. Stifel Nicolaus boosted their price target on shares of Beauty Health from $3.00 to $4.00 and gave the stock a "hold" rating in a report on Friday, August 1st. Weiss Ratings reiterated a "sell (e+)" rating on shares of Beauty Health in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Beauty Health from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Finally, Roth Capital assumed coverage on shares of Beauty Health in a report on Friday, September 19th. They issued a "buy" rating and a $3.50 target price for the company. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $2.81.

Beauty Health Trading Down 0.7%

Shares of SKIN stock opened at $1.33 on Tuesday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 4.15 and a current ratio of 5.15. The stock has a market capitalization of $168.67 million, a P/E ratio of -4.75 and a beta of 1.21. The company has a 50 day moving average price of $1.98 and a 200 day moving average price of $1.71. Beauty Health has a fifty-two week low of $0.78 and a fifty-two week high of $2.69.

Beauty Health (NASDAQ:SKIN - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.06) by $0.09. The firm had revenue of $78.20 million during the quarter, compared to analysts' expectations of $74.67 million. Beauty Health had a negative net margin of 6.13% and a negative return on equity of 32.82%. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts predict that Beauty Health will post -0.25 EPS for the current fiscal year.

Institutional Trading of Beauty Health

Institutional investors and hedge funds have recently bought and sold shares of the business. ProShare Advisors LLC raised its position in Beauty Health by 45.5% in the 2nd quarter. ProShare Advisors LLC now owns 23,447 shares of the company's stock valued at $45,000 after purchasing an additional 7,336 shares during the last quarter. Simplicity Wealth LLC purchased a new position in Beauty Health during the 2nd quarter worth $49,000. AQR Capital Management LLC purchased a new position in Beauty Health during the 1st quarter worth $40,000. Police & Firemen s Retirement System of New Jersey raised its position in Beauty Health by 87.5% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 31,408 shares of the company's stock worth $60,000 after buying an additional 14,653 shares during the last quarter. Finally, Kapitalo Investimentos Ltda purchased a new position in Beauty Health during the 2nd quarter worth $60,000. Hedge funds and other institutional investors own 93.26% of the company's stock.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.